People with diabetes who suffer a myocardial infarction face markedly worse outcomes than non-diabetic individuals. Diabetes doubles the risk of early mortality and sustains elevated rates of heart ...
Clinical auditing reveals significant misclassification in administrative codes for myocardial infarction (MI), with only 39% of type 1 (T1MI) codes and 72% of type 2 (T2MI) codes for the condition ...
Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results